Advertisement

Molecular Medicine

, Volume 18, Issue 3, pp 455–465 | Cite as

Genipin Attenuates Sepsis by Inhibiting Toll-Like Receptor Signaling

  • Tae-Hoon Kim
  • Seong-Jin Yoon
  • Sun-Mee Lee
Research Article

Abstract

The pathogenesis of sepsis is characterized by overwhelming inflammatory responses that lead to tissue damage and organ failure. Toll-like receptor (TLR) signaling is crucial for induction of hyperinflammatory responses and tissue injury during sepsis. Genipin, an aglycon of geniposide, has antiinflammatory and antimicrobial activities. The purpose of this study was to test the hypothesis that genipin reduces multiple organ dysfunction and mortality during sepsis through inhibition of TLR signaling. Male ICR were subjected to sepsis by cecal ligation and puncture (CLP) or endotoxemia by lipopolysaccharide (LPS). Various doses of genipin (1),2.5 and 5 mg/kg) or a vehicle were administered intravenously immediately after CLP or intraperitoneally after LPS treatment. In another set of survival tests, mice were treated with 2.5 mg/kg of genipin 0 and 24 h after CLP. Genipin was found to improve survival and to attenuate multiple organ dysfunction. Genipin attenuated production of proinflammatory cytokines and release of high-mobility group box 1 (HMGB1). Genipin prevented TLR2 and TLR4, myeloid differentiation factor 88 and the Toll/interleukin-1 receptor domain-containing adaptor protein, inducing interferon-β overexpression. Phosphorylation of mitogen-activated protein kinases and interferon regulatory factor 3 and translocation of nuclear factor (NF)-κB were prevented by genipin. Moreover, genipin attenuated increases in serum tumor necrosis factor-α and HMGB1 in LPS-induced endotoxemia. Pam3CSK4- and LPS-mediated production of nitrites and proinflammatory cytokines was suppressed by genipin in RAW264.7 cells. Genipin attenuated mortality and organ injuries during sepsis through interference with TLR signaling. Therefore, genipin might be useful as a potential therapeutic agent for treatment of sepsis.

Notes

Acknowledgments

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (2010-0028646).

References

  1. 1.
    van der Poll T, Opal SM. (2008) Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8:32–43.CrossRefGoogle Scholar
  2. 2.
    Xie J, Lv R, Yu L, Huang W. (2010) Hydroxyethyl starch 130/0.4 inhibits production of plasma proinflammatory cytokines and attenuates nuclear factor-kappaB activation and Toll-like receptors expression in monocytes during sepsis. J. Surg. Res. 160:133–8.CrossRefGoogle Scholar
  3. 3.
    Cinel I, Opal SM. (2009) Molecular biology of inflammation and sepsis: a primer. Crit. Care Med. 37:291–304.CrossRefGoogle Scholar
  4. 4.
    Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB. (2004) Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin. Exp. Immunol. 136:312–9.CrossRefGoogle Scholar
  5. 5.
    Famakin BM, et al. (2011) Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia. Brain Res. 1388:148–56.CrossRefGoogle Scholar
  6. 6.
    Koo HJ, Lim KH, Jung HJ, Park EH. (2006) Antiinflammatory evaluation of gardenia extract, geniposide and genipin. J. Ethnopharmacol. 103:496–500.CrossRefGoogle Scholar
  7. 7.
    Koo HJ, et al. (2004) Antiinflammatory effects of genipin, an active principle of gardenia. Eur. J. Pharmacol. 495:201–8.CrossRefGoogle Scholar
  8. 8.
    Takeuchi S, et al. (2005) Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-alpha production. Hepatol. Res. 33:298–305.CrossRefGoogle Scholar
  9. 9.
    Chaudry IH, Wichterman KA, Baue AE. (1979) Effect of sepsis on tissue adenine nucleotide levels. Surgery 85:205–11.PubMedGoogle Scholar
  10. 10.
    Matsuda A, et al. (2005) Dehydroepiandrosterone modulates Toll-like receptor expression on splenic macrophages of mice after severe polymicrobial sepsis. Shock 24:364–9.CrossRefGoogle Scholar
  11. 11.
    Ishiguro K, Yamaki M, Takagi S. (1983) Studies on iridoid-related compounds, II. The structure and antimicrobial activity of aglucones of galioside and gardenoside. J. Nat. Prod. 46:532–6.CrossRefGoogle Scholar
  12. 12.
    Nam KN, et al. (2010) Genipin inhibits the inflammatory response of rat brain microglial cells. Int. Immunopharmacol. 10:493–9.CrossRefGoogle Scholar
  13. 13.
    Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL. (1996) Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733–8.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Huang W, Tang Y, Li L. (2010) HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51:119–26.CrossRefGoogle Scholar
  15. 15.
    Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248–51.CrossRefGoogle Scholar
  16. 16.
    Ulloa L, et al. (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. U. S. A. 99:12351–6.CrossRefGoogle Scholar
  17. 17.
    Wang H, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10:1216–21.CrossRefGoogle Scholar
  18. 18.
    Wu JY, et al. (2008) Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. J. Pineal Res. 45:106–16.CrossRefGoogle Scholar
  19. 19.
    Bone RC. (1991) The pathogenesis of sepsis. Ann. Intern. Med. 115:457–69.CrossRefGoogle Scholar
  20. 20.
    Matuschak GM, Rinaldo JE. (1988) Organ interactions in the adult respiratory distress syndrome during sepsis: role of the liver in host defense. Chest. 94:400–6.CrossRefGoogle Scholar
  21. 21.
    Holtzman MJ. (1991) Arachidonic acid metabolism: implications of biological chemistry for lung function and disease. Am. Rev. Respir. Dis. 143:188–203.CrossRefGoogle Scholar
  22. 22.
    Williams DL, et al. (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 31:1808–18.CrossRefGoogle Scholar
  23. 23.
    Zou L, et al. (2010) Toll-like receptor 2 plays a critical role in cardiac dysfunction during polymicrobial sepsis. Crit. Care Med. 38:1335–42.CrossRefGoogle Scholar
  24. 24.
    Takashima K, et al. (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br. J. Pharmacol. 157:1250–62.CrossRefGoogle Scholar
  25. 25.
    Weighardt H, et al. (2004) Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur. J. Immunol. 34:558–64.CrossRefGoogle Scholar
  26. 26.
    Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115–22.CrossRefGoogle Scholar
  27. 27.
    Yang M, Wu J, Martin CM, Kvietys PR, Rui T. (2008) Important role of p38 map kinase/NF-kappaB signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype. Am. J. Physiol. 294:H994–1001.CrossRefGoogle Scholar
  28. 28.
    Chen LC, Gordon RE, Laskin JD, Laskin DL. (2007) Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia. Exp. Mol. Pathol. 83:311–26.CrossRefGoogle Scholar
  29. 29.
    Jiang B, et al. (2004) Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. J. Biol. Chem. 279:1323–9.CrossRefGoogle Scholar
  30. 30.
    Maitra SR, et al. (2003) Modulations of signal transduction pathways during sepsis and the effects of insulin and mifepristone. Acad. Emerg. Med. 10:1–8.CrossRefGoogle Scholar
  31. 31.
    Baeuerle PA, Baltimore D. (1996) NF-kappaB: Ten years after. Cell. 87:13–20.CrossRefGoogle Scholar
  32. 32.
    Akira S, Kawai T. (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immuniny. Immunity. 34:637–50.CrossRefGoogle Scholar
  33. 33.
    Yamamoto M, et al. (2003) Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science. 301:640–3.CrossRefGoogle Scholar
  34. 34.
    Bjorkbacka H, et al. (2004) The induction of macrophage gene expression by LPS predominantly utilizes MyD88-independent signaling cascades. Physiol. Genomics. 19:319–30.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2012

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  1. 1.School of PharmacySungkyunkwan UniversitySuwonKorea

Personalised recommendations